📰 Multiple Ascending Dose News
Multiple Ascending Dose News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multiple Ascending Dose. Real-time updates on events, politics, business and more.
May 22, 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / May 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 22, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and
May 22, 2024
IRLAB Therapeutics AB announced that dosing has been initiated in a Phase I study of the drug candidate IRL757. IRL757 has been shown in preclinical disease models to counteract apathy - a condition...
April 25, 2024
MIAMI, FL, April 25, 2024 -- Veru Inc. , a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and...
February 27, 2024
BETHESDA, Md., Feb. 27, 2024 -- Gain Therapeutics, Inc. , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule...
December 14, 2023
GHENT, Belgium, December 14, 2023--Agomab Therapeutics NV (‘Agomab’) today announced that it has dosed the first subject in a first-in-human Phase 1 clinical study of AGMB-447, an inhaled lung-restricted small molecule inhibitor of ALK5 (TGFβRI or ALK5). The study is evaluating AGMB-447 in healthy subjects and in patients with idiopathic pulmonary fibrosis (IPF).
December 8, 2023
BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes At Week 26, 22 weeks after the last dose of BMF-219,...
December 5, 2023
ST. LOUIS, Mo. & CONCORD, Mass.--(BUSINESS WIRE)--Dec 5, 2023--
December 5, 2023
Adiso to Utilize Noninvasive RNA Technology Developed by Geneoscopy as a Precision Immunology Measure in ADS051 Phase 2 IBD TrialST. LOUIS, Mo. & CONCORD, Mass.--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing noninvasive diagnostic and precision medicine tools for gastrointestinal h...
November 28, 2023
28.11.2023 - SHELTON, CT / ACCESSWIRE / November 28, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the Company), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, reported today that the ... Seite 1
November 28, 2023
The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum ...